NEWS

Ankyra Therapeutics Announces $45M Series B and Appointment of Chief Medical Officer	11.12.21
Compass Announces Pricing of $125M Public Offering and Uplisting to Nasdaq	11.01.21
Compass Reports the Advancement of CTX-009 to Phase 2a	11.01.21
Landmark Paper Highlights Evox's Exosome Engineering Approach	10.07.21
Teckro Launches Next-Gen Clinical Trial Mobile Platform	09.29.21
Repligen Announces Agreement to Acquire Avitide	09.16.21

Page 1 of 9